Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders

 
 

scPharmaceuticals Inc. (SCPH) Add to portfolio

1m | 3m | 6m | 1y | 2y | 5y | 10yscPharmaceuticals Inc is a pharmaceutical company. Its pipeline includes products in various stages of clinical and non-clinical development. It focuses on proven pharmaceutical products in the cardiovascular and infectious disease therapeutic areas.

CEO: John H. Tucker
http://www.scpharmaceuticals.com
Price: $4.67 Metrics
OS: 18.5 M
Market cap: $86.6 M
Net cash: $118 M $6.38 per share
EV:

 
TTM Valuation
EBITDA
EBIT
EPS

Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-17Dec-31-16Dec-31-15
Revenues14.311.98.3
            Revenue growth20.9%43.4% 
Cost of goods sold23.417.910.8
Gross profit-9.1-6.1-2.6
            Gross margin-63.5%-51.1%-31.2%
General and administrative9.16.12.6
EBIT-23.4-17.9-10.8
            EBIT margin-163.5%-151.1%-131.2%
Pre-tax income0.00.00.0
Income taxes0.00.00.0
Net income0.00.00.0
            Net margin0.0%0.0%0.0%
 
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2018 | Contact Us | Data Disclaimer | Terms of Use | Privacy